eMarketer reports the platform is restricting peptide search results as worry grows over unapproved products promoted in wellness content.
Recap by typeshit. Full story at eMarketer.
WebMD notes that eating less on a GLP-1 can mean missing some nutrients, and suggests asking your doctor about nutrition while on the drug.
The FDA notice says the pharmacy can't assure the vials are sterile. Check the full details to see which compounded products are affected.
Doctors describe a patient who developed a bowel obstruction after moving from tirzepatide to semaglutide unsupervised, following a long break in treatment.
PIX11 reports the recall covers 23 compounded GLP-1 vials because there is no assurance they are sterile. Check the list if you use compounded shots.
Retatrutide has no FDA approval and is still being tested, yet CBS News says it is being advertised widely. Worth a look for anyone seeing those promos.
KMOV shares an InvestigateTV+ piece on the national weight loss trend and what coverage your insurance plan might offer. Details are thin in the clip.
Loading…